Table 4 Choice of antifungals for treatment of candidemia in critically ill patients
From: Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Treatment | First choice | Alternative |
|---|---|---|
Pre-emptive or empirical | Echinocandin | Lipid formulation of amphotericin B |
Culture-proven candidemia | Â | Â |
   Candida albicans | Echinocandin | Fluconazole or lipid formulation of amphotericin B |
   Candida glabrata | Echinocandin | Lipid formulation of amphotericin B |
   Candida krusei | Echinocandin | Lipid formulation of amphotericin B |
   Candida parapsilosis | Lipid formulation of amphotericin B | Echinocandin or fluconazole |